Projects
Explore a selection of our current and past research projects.
An open, prospective Phase III clinical study to compare polatuzumab vedotin plus rituximab, ifosfamide, carboplatin and etoposide (PolaRICE) with rituximab, ifosfamide, carboplatin and etoposide (RICE) alone as salvage-therapy in patients with diffuse la
Status: ActiveLead researchers: Andrew John DaviesCellulitis antibiotic treatment duration (COAT)
Status: ActiveLead researchers: Nicholas Andrew FrancisCRAIN (Astex) - Non-staff budget
Status: ActiveLead researchers: Gareth Owen GriffithsCTU - CCTG- Crabb - A RANDOMIZED PHASE II TRIAL ASSESSING TRIMODALITY THERAPY WITH OR WITHOUT ADJUVANT DURVALUMAB TO TREAT PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER
Status: ActiveLead researchers: Gareth Owen GriffithsOptimizing MATrix as remission induction treatment for newly diagnosed primary CNS Lymphoma – a randomized phase III trial (OPTIMATE trial)
Status: ActiveLead researchers: Gareth Owen GriffithsTip Study 2
Status: ActiveLead researchers: Hazel Anne EverittA DAVIES - A Phase 1b/11 combination of ACP-196 with Rituximiab, Cyclophosphamide, doxorubicin, Vincristine and Prenisolone (R-CHOP) for patients with Diffused B-cell Lymphoma (DLBCL) - "ACCEPT" - ACP-196 - ACERTA
Status: Not activeLead researchers: Gareth Owen GriffithsA multicentre randomised controlled trial (RCT) of a uro-oncology clinical nurse specialist (CNS) team delivered cognitive behavioural therapy (CBT) intervention to reduce the impact of hot flush and night sweat (HFNS) symptoms in men with prostate cancer
Status: Not activeLead researchers: Simon CrabbAGILE: CST 3 Nitazoxanide
Status: Not activeLead researchers: Gareth Owen GriffithsDebbie Fenlon, Breast Cancer Now - MENOS4: A multicentre Randomised Controlled Trial (RCT) of a breast care nurse delivered cognitive behavioural therapy (CBT) intervention to reduce the impact of hot flushes in women with breast cancer
Status: Not active